Dr. Akhilesh Vats

Dr. Akhilesh Vats is a pharmaceutical scientist, formulation researcher, founder of ACME Research Solutions, ISEF Qualified Scientist 2026, and Editor-in-Chief at PEXACY International Journal of Pharmaceutical Science. He also serves as an editor at The Witfire Elite Pharma News, where his editorial focus is to make pharma news more useful for serious readers by adding scientific context, regulatory interpretation, market consequence, and business-level meaning.

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure

/ Pharma News /

The Middle East conflict is now moving directly into pharma boardroom risk. Oil-market stress has intensified, with Vitol’s Bahrain chief warning that the market may still be underpricing the impact of disrupted Middle East supply, including a reported removal of nearly 14 million barrels per day from normal supply flows. Crude prices reportedly spiked as […]

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure Read More »

pharma-stock-market-news-war-impact-drug-supply-chain

Pharma Stock Market News: US-Israel-Iran War Impact on Drug Supply Chains, Oil Prices and Healthcare Stocks

/ Stock Market /

The stock market is now looking at the US-Israel-Iran conflict through a sharper pharma lens. This is no longer only a war story, an oil story, or a Wall Street volatility story. For pharmaceutical companies, this conflict has become a supply-chain test, a margin test, and a leadership test. Global markets turned cautious as fresh

Pharma Stock Market News: US-Israel-Iran War Impact on Drug Supply Chains, Oil Prices and Healthcare Stocks Read More »

Pharma market risks amid global tensions

Pharma Stock Market News: US-Israel-Iran War Impact on Drug Companies, Oil Prices, and Pharma Supply Chains

/ Stock Market /

The US-Israel-Iran war is affecting pharma stocks, drug supply chains, logistics costs, cold-chain movement, and investor sentiment as oil and freight costs rise. The US-Israel-Iran war is now becoming more than a geopolitical headline for the pharmaceutical industry. For pharma CEOs, investors, exporters, logistics companies, and healthcare suppliers, the conflict is creating a new layer

Pharma Stock Market News: US-Israel-Iran War Impact on Drug Companies, Oil Prices, and Pharma Supply Chains Read More »

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious

/ Pharma News /

The pharmaceutical business is no longer a small product-driven market. It is becoming one of the most strategic global industries. IQVIA has projected that global medicine spending may reach nearly USD 2.3 trillion by 2028. This growth is not only due to price increases. It is also linked with higher patient access, stronger use of

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious Read More »

Scroll to Top